Breaking News Instant updates and real-time market news.

GME

GameStop

$4.25 /

-0.61 (-12.55%)

07:17
09/11/19
09/11
07:17
09/11/19
07:17

GameStop strategy updated but headwinds remain, says Baird

Baird analyst Peter Benedict noted GameStop reported another disappointing quarter but said management outlines a new strategy to improve profitability and drive deeper customer engagement. The analyst believes despite the new focus, the near-term impact of an eroding console cycle is likely to more than offset any material improvements. Benedict maintained his Neutral rating and $6 price target on GameStop shares.

  • 12

    Sep

GME GameStop
$4.25 /

-0.61 (-12.55%)

09/03/19 Loop Capital
GameStop price target lowered to $4 from $7 at Loop Capital
08/20/19 BofA
GameStop price target lowered to $2.50 from $4 at BofA/Merrill
07/15/19 Loop Capital
GameStop Dutch tender auction a 'sensible' capital allocation, says Loop Capital
06/05/19 Ascendiant
GameStop downgraded to Hold from Buy at Ascendiant

TODAY'S FREE FLY STORIES

Recommendations
Lyft price target lowered to $66 from $75 at Credit Suisse » 07:41
08/10/20
08/10
07:41
08/10/20
07:41
LYFT

Lyft

$30.19 /

-2.145 (-6.63%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

08/05/20 Deutsche Bank
Lyft price target lowered to $57 from $60 at Deutsche Bank
07/22/20 Raymond James
Lyft resumed with a Market Perform at Raymond James
07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 Northcoast
Lyft downgraded to Neutral from Buy at Northcoast
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

Earnings
Tegna reports Q2 EPS 12c, consensus 12c » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
TGNA

Tegna

$11.91 /

+0.205 (+1.75%)

Reports Q2 revenue $578M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

04/16/20 Wells Fargo
Tegna price target lowered to $11 from $18 at Wells Fargo
04/13/20 JPMorgan
Tegna price target lowered to $13 from $19 at JPMorgan
04/03/20 Barrington
Tegna price target lowered to $15 from $20 at Barrington
01/17/20 Argus
Tegna price target raised to $21 from $17 at Argus
TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

Hot Stocks
Baudax Bio says efforts to commercialze ANJESO impacted by COVID-19 » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
BXRX

Baudax Bio

$3.45 /

-0.025 (-0.72%)

The Company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
02/21/20 Piper Sandler
Baudax Bio price target raised to $14 from $11 at Piper Sandler
11/22/19 Janney Montgomery Scott
Baudax Bio initiated with a Buy at Janney Montgomery Scott
11/22/19 Piper Jaffray
Baudax Bio initiated with an Overweight at Piper Jaffray
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

  • 24
    Mar
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

Recommendations
Trade Desk price target raised to $490 from $300 at DA Davidson » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
TTD

Trade Desk

$493.98 /

+13.62 (+2.84%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

08/07/20 RBC Capital
Trade Desk price target raised to $510 from $300 at RBC Capital
08/07/20 Stephens
Trade Desk downgraded to Equal Weight from Overweight at Stephens
08/07/20 Stephens
Trade Desk downgraded to Equal Weight from Overweight at Stephens
06/22/20 Needham
Trade Desk price target raised to $475 from $370 at Needham
TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

Earnings
Baudax Bio reports Q2 EPS ($1.72), consensus (65c) » 07:39
08/10/20
08/10
07:39
08/10/20
07:39
BXRX

Baudax Bio

$3.45 /

-0.025 (-0.72%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
02/21/20 Piper Sandler
Baudax Bio price target raised to $14 from $11 at Piper Sandler
11/22/19 Janney Montgomery Scott
Baudax Bio initiated with a Buy at Janney Montgomery Scott
11/22/19 Piper Jaffray
Baudax Bio initiated with an Overweight at Piper Jaffray
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

  • 24
    Mar
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

Earnings
Sesen Bio reports Q2 EPS (24c), consensus (9c) » 07:39
08/10/20
08/10
07:39
08/10/20
07:39
SESN

Sesen Bio

$1.00 /

-0.01 (-0.99%)

"We are extremely…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

Recommendations
Mosaic price target raised to $17 from $14 at Goldman Sachs » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
MOS

Mosaic

$17.19 /

+1.05 (+6.51%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

07/15/20 Citi
Mosaic upgraded to Buy from Neutral at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 BofA
Mosaic upgraded to Buy from Underperform at BofA
05/11/20 BofA
Nutrien, Mosaic, Corteva, CF Industries cut to Underperform at BofA
MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

Hot Stocks
Omeros reports recovery, survival of all COVID patients in study of narsoplimab » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
OMER

Omeros

$14.13 /

+0.12 (+0.86%)

Omeros said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMER Omeros
$14.13 /

+0.12 (+0.86%)

OMER Omeros
$14.13 /

+0.12 (+0.86%)

03/04/20 Wedbush
Omeros price target raised to $22 from $18 at Wedbush
03/03/20 Cantor Fitzgerald
Omeros shares can 'significantly rerate' from here, says Cantor Fitzgerald
11/05/19 H.C. Wainwright
Omeros recent selloff appears unwarranted, says H.C. Wainwright
OMER Omeros
$14.13 /

+0.12 (+0.86%)

  • 05
    Dec
OMER Omeros
$14.13 /

+0.12 (+0.86%)

Hot Stocks
Navidea, Jubilant sign MOU worth $19M for Rheumatoid Arthritis Diagnostic ELDA » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
NAVB

Navidea

$4.71 /

-0.09 (-1.88%)

Navidea announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

NAVB Navidea
$4.71 /

-0.09 (-1.88%)

05/22/20 H.C. Wainwright
Navidea price target raised to $6 from $4 at H.C. Wainwright
11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

Hot Stocks
Axsome Therapeutics expects cash to fund operations for at least two years » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Axsome believes that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Mr. Cooper price target raised to $24 from $16 at Credit Suisse » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
COOP

Mr. Cooper

$17.98 /

-0.26 (-1.43%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

08/03/20 Piper Sandler
Mr. Cooper price target raised to $25 from $15 at Piper Sandler
07/31/20 Barclays
Barclays upgrades Mr. Cooper to Overweight with refis in 'earlier innings'
07/31/20 Barclays
Mr. Cooper upgraded to Overweight from Equal Weight at Barclays
07/07/20 KeyBanc
Mr. Cooper price target raised to $14 from $12 at KeyBanc
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

Hot Stocks
Axsome Therapeutics announces anticipated milestones » 07:37
08/10/20
08/10
07:37
08/10/20
07:37
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Anticipated Milestones:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
ABC

AmerisourceBergen

$102.10 /

+0.5 (+0.49%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

Earnings
Axsome Therapeutics reports Q2 EPS (49c), consensus (62c) » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

"Axsome is committed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Etsy price target raised to $160 from $90 at DA Davidson » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
ETSY

Etsy

$135.21 /

+4.55 (+3.48%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

08/06/20 KeyBanc
Etsy price target raised to $150 from $115 at KeyBanc
08/06/20
Fly Intel: Top five analyst upgrades
08/06/20 Morgan Stanley
Morgan Stanley stays Underweight on Etsy, wonder is this 'as good as it gets?'
08/06/20 Truist
Etsy price target raised to $162 from $112 at Truist
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

Hot Stocks
Synchronoss sees 2020 adjusted EBITDA $20M-$25M » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

The company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

Upgrade
Pinterest upgraded to Overweight on social shopping trend at Morgan Stanley » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
PINS

Pinterest

$35.04 /

-0.85 (-2.37%)

, FB

Facebook

$268.52 /

+3.295 (+1.24%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

07:01 Today Morgan Stanley
Pinterest upgraded to Overweight from Equal Weight at Morgan Stanley
08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
FB Facebook
$268.52 /

+3.295 (+1.24%)

06:55 Today Mizuho
Facebook price target raised to $315 from $285 at Mizuho
08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

  • 16
    Oct
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

Options
Unusual call flow in option market yesterday » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
FB

Facebook

$268.52 /

+3.295 (+1.24%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

06:55 Today Mizuho
Facebook price target raised to $315 from $285 at Mizuho
08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

Initiation
Credit Suisse bullish on GoHealth, initiates with an Outperform » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

07:22 Today Evercore ISI
GoHealth initiated with an Outperform at Evercore ISI
07:21 Today Truist
GoHealth initiated with a Buy at Truist
06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Synchronoss reports Q2 EPS 16c, consensus (21c) » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

Reports Q revenue $76.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

Hot Stocks
Precigen announces results from Phase 1b/2a study of AG019 ActoBiotics » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
PGEN

Precigen

$4.87 /

+0.1 (+2.10%)

Precigen ActoBio, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGEN Precigen
$4.87 /

+0.1 (+2.10%)

PGEN Precigen
$4.87 /

+0.1 (+2.10%)

05/08/20
Fly Intel: Top analyst initiations
05/08/20 H.C. Wainwright
Precigen initiated with a Buy at H.C. Wainwright
PGEN Precigen
$4.87 /

+0.1 (+2.10%)

Hot Stocks
Hexindai announces ADS ratio change » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
HX

Hexindai

$0.70 /

-0.0219 (-3.05%)

Hexindai announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HX Hexindai
$0.70 /

-0.0219 (-3.05%)

Hot Stocks
Momenta says Mylan expects U.S. submission for M710 in 2021 » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
MYL

Mylan

$16.35 /

-0.07 (-0.43%)

, MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Mylan continues its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

Earnings
Stoke Therapeutics reports Q2 EPS (39c), consensus (35c) » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
STOK

Stoke Therapeutics

$26.82 /

+0.5 (+1.90%)

"Today we are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
11/12/19
Fly Intel: Top five analyst initiations
11/12/19 BTIG
Stoke Therapeutics initiated with a Buy at BTIG
STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

Hot Stocks
Momenta exploring utility of necuparanib for COVID-19 » 07:32
08/10/20
08/10
07:32
08/10/20
07:32
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

The Company is currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.